Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Harvard Business School
Colorcon
Queensland Health
Fuji
Covington
Accenture
Julphar
Boehringer Ingelheim

Generated: October 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074988

« Back to Dashboard

NDA 074988 describes ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE, which is a drug marketed by Sandoz and Stevens J and is included in two NDAs. It is available from one supplier. Additional details are available on the ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE profile page.

The generic ingredient in ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE is aspirin; caffeine; orphenadrine citrate. There are twenty-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the aspirin; caffeine; orphenadrine citrate profile page.
Summary for 074988

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength385MG;30MG;25MG
Approval Date:Apr 30, 1999TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength770MG;60MG;50MG
Approval Date:Apr 30, 1999TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Federal Trade Commission
Merck
Queensland Health
Medtronic
Cerilliant
Julphar
Teva
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.